LTFS
IONS icon

Ladenburg Thalmann Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.02M Sell
17,084
-28
-0.2% -$1.67K 0.01% 1268
2019
Q3 		$1.02M Buy
17,112
+1,028
+6% +$67K 0.01% 1235
2019
Q2 		$1.04M Buy
16,084
+154
+1% +$10.9K 0.01% 1205
2019
Q1 		$1.29M Buy
15,930
+797
+5% +$51.4K 0.01% 1014
2018
Q4 		$819K Sell
15,133
-2,629
-15% -$134K 0.01% 1178
2018
Q3 		$917K Sell
17,762
-478
-3% -$22.5K 0.01% 1172
2018
Q2 		$805K Hold
18,240
– – 0.01% 1199
2018
Q1 		$805K Buy
18,240
+973
+6% +$49.4K 0.01% 1199
2017
Q4 		$869K Sell
17,267
-120
-0.7% -$6.58K 0.01% 1154
2017
Q3 		$882K Sell
17,387
-31
-0.2% -$1.62K 0.01% 1071
2017
Q2 		$887K Buy
17,418
+384
+2% +$17.9K 0.01% 1017
2017
Q1 		$684K Buy
17,034
+907
+6% +$40.7K 0.01% 1113
2016
Q4 		$771K Sell
16,127
-3,547
-18% -$140K 0.01% 993
2016
Q3 		$721K Buy
19,674
+1,134
+6% +$35.5K 0.01% 976
2016
Q2 		$432K Buy
18,540
+5,994
+48% +$193K 0.01% 1214
2016
Q1 		$508K Buy
12,546
+2,091
+20% +$84.9K 0.01% 1050
2015
Q4 		$647K Sell
10,455
-1,283
-11% -$69.2K 0.01% 886
2015
Q3 		$475K Sell
11,738
-2,040
-15% -$106K 0.01% 996
2015
Q2 		$794K Sell
13,778
-1,035
-7% -$65.8K 0.01% 832
2015
Q1 		$944K Buy
14,813
+3,761
+34% +$255K 0.02% 716
2014
Q4 		$678K Buy
11,052
+2,301
+26% +$114K 0.02% 778
2014
Q3 		$340K Buy
8,751
+2,224
+34% +$78.8K 0.01% 964
2014
Q2 		$224K Buy
6,527
+1,806
+38% +$56.9K 0.01% 1141
2014
Q1 		$206K Sell
4,721
-1,712
-27% -$83K 0.01% 1113
2013
Q4 		$256K Buy
6,433
+706
+12% +$25.2K 0.01% 962
2013
Q3 		$215K Sell
5,727
-19
-0.3% -$568 0.01% 983
2013
Q2 		$155K Buy
+5,746
New +$122K 0.01% 1090

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IONS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 0.16% in Q4 2019, selling an estimated $1.67K and leaving 17,084 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #1268.

Ladenburg Thalmann Financial Services first reported a position in IONS in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.29M in Q1 2019. 390 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 17,084 shares of Ionis Pharmaceuticals worth $1.02M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 28 Ionis Pharmaceuticals shares in Q4 2019, an estimated $1.67K.
  • Ionis Pharmaceuticals made up 0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1268 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Ionis Pharmaceuticals position peaked at $1.29M in Q1 2019.
  • 390 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.